1. Home
  2. PAX vs GLPG Comparison

PAX vs GLPG Comparison

Compare PAX & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$17.14

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$34.45

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAX
GLPG
Founded
1988
1999
Country
Cayman Islands
Belgium
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
PAX
GLPG
Price
$17.14
$34.45
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$31.33
AVG Volume (30 Days)
457.2K
122.6K
Earning Date
02-10-2026
02-11-2026
Dividend Yield
3.47%
N/A
EPS Growth
58.69
N/A
EPS
0.66
N/A
Revenue
$405,792,000.00
$336,643,201.00
Revenue This Year
N/A
$1.76
Revenue Next Year
$22.55
$0.49
P/E Ratio
$26.04
N/A
Revenue Growth
23.45
10.31
52 Week Low
$9.43
$22.36
52 Week High
$17.80
$37.78

Technical Indicators

Market Signals
Indicator
PAX
GLPG
Relative Strength Index (RSI) 60.27 68.91
Support Level $16.86 $32.13
Resistance Level $17.58 $34.48
Average True Range (ATR) 0.44 0.81
MACD -0.04 0.09
Stochastic Oscillator 65.96 92.58

Price Performance

Historical Comparison
PAX
GLPG

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: